These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12732935)

  • 41. [Electron microscopic study of hyaline inclusions in meningioma (author's transl)].
    Kubota T; Hirano A; Yamamoto S
    No Shinkei Geka; 1982 May; 10(5):521-8. PubMed ID: 6180345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurofilament subunit--related proteins in neuronal intranuclear inclusions.
    Palo J; Haltia M; Carpenter S; Karpati G; Mushynski W
    Ann Neurol; 1984 Apr; 15(4):322-8. PubMed ID: 6331276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The spatial patterns of pathological brain lesions in 12 patients with corticobasal degeneration.
    Armstrong RA; Lantos PL; Cairns NJ
    Pathophysiology; 2001 Aug; 8(1):47-53. PubMed ID: 11476973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex.
    Kuljis RO; Martín-Vasallo P; Peress NS
    Neurosci Lett; 1989 Nov; 106(1-2):49-54. PubMed ID: 2573869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive dementia and epilepsy in a young adult: unusual intraneuronal inclusions.
    Yerby MS; Shaw CM; Watson JM
    Neurology; 1986 Jan; 36(1):68-71. PubMed ID: 3001585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clustering and spatial correlations of the neuronal cytoplasmic inclusions, astrocytic plaques and ballooned neurons in corticobasal degeneration.
    Armstrong RA; Cairns NJ
    J Neural Transm (Vienna); 2009 Sep; 116(9):1103-10. PubMed ID: 19551469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrastructural study of a patient with progressive dementia showing special intraplasmic inclusions in diffuse cerebral cortex. Mechanism of inclusions production.
    Miyakawa T; Shikai I; Shimoji A; Nagatoshi K; Mimura K
    Acta Neuropathol; 1978 Dec; 44(3):223-8. PubMed ID: 216222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adult-onset neuronal intranuclear hyaline inclusion disease.
    Munoz-Garcia D; Ludwin SK
    Neurology; 1986 Jun; 36(6):785-90. PubMed ID: 3010181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aluminum neurotoxicity: an experimental approach to the induction of neurofilamentous inclusions.
    Strong MJ
    J Neurol Sci; 1994 Jul; 124 Suppl():20-6. PubMed ID: 7807137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intranuclear inclusions in mouse neurons.
    Kroh H
    Neuropatol Pol; 1984; 22(1):139-56. PubMed ID: 6330615
    [No Abstract]   [Full Text] [Related]  

  • 51. Case for the panel. Unusual lymphocytic inclusions.
    Richert JR; Manz HJ; Rusnock E; Hartmann DP
    Ultrastruct Pathol; 1992; 16(3):391-5. PubMed ID: 1316661
    [No Abstract]   [Full Text] [Related]  

  • 52. Green neutrophilic inclusions: current understanding and review of literature.
    Yang J; Gabali A
    Curr Opin Hematol; 2018 Jan; 25(1):3-6. PubMed ID: 29211696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preliminary isolation and fine structure analysis of the Alzheimer neurofilament.
    Shelanski ML; Wisniewski H; Terry RD
    J Neuropathol Exp Neurol; 1971 Jan; 30(1):146-7. PubMed ID: 5100706
    [No Abstract]   [Full Text] [Related]  

  • 54. Electrical response of heterogeneous systems of clustered inclusions.
    Fu L; Resca L
    Phys Rev B Condens Matter; 1993 Jun; 47(24):16194-16204. PubMed ID: 10006041
    [No Abstract]   [Full Text] [Related]  

  • 55. Paleoenvironment. Clues from fluid inclusions.
    Goldstein RH
    Science; 2001 Nov; 294(5544):1009-11. PubMed ID: 11691973
    [No Abstract]   [Full Text] [Related]  

  • 56. PRKAR1B mutations are a rare cause of FUS negative neuronal intermediate filament inclusion disease.
    Pottier C; Baker M; Dickson DW; Rademakers R
    Brain; 2015 Jun; 138(Pt 6):e357. PubMed ID: 25414037
    [No Abstract]   [Full Text] [Related]  

  • 57. Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).
    Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
    J Neural Transm (Vienna); 2011 Nov; 118(11):1651-7. PubMed ID: 21792670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.
    Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
    Acta Neuropathol; 2011 Feb; 121(2):219-28. PubMed ID: 20886222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.
    Armstrong RA; Cairns NJ
    J Neural Transm (Vienna); 2007; 114(4):451-6. PubMed ID: 17109074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.
    Cairns NJ; Uryu K; Bigio EH; Mackenzie IR; Gearing M; Duyckaerts C; Yokoo H; Nakazato Y; Jaros E; Perry RH; Arnold SE; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2004 Sep; 108(3):213-23. PubMed ID: 15170578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.